Farther Finance Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03K | Sell |
475
-3,195
| -87% | -$20.4K | ﹤0.01% | 3544 |
|
|
2025
Q1 | $17.4K | Buy |
3,670
+3,175
| +641% | +$15.1K | ﹤0.01% | 2454 |
|
|
2024
Q4 | $4.73K | Sell |
495
-60
| -11% | -$574 | ﹤0.01% | 2693 |
|
|
2024
Q3 | $4.63K | Sell |
555
-69
| -11% | -$576 | ﹤0.01% | 2676 |
|
|
2024
Q2 | $4.41K | Buy |
624
+136
| +28% | +$960 | ﹤0.01% | 2452 |
|
|
2024
Q1 | $1.12K | Buy |
488
+39
| +9% | +$90 | ﹤0.01% | 2726 |
|
|
2023
Q4 | $1.08K | Buy |
449
+429
| +2,145% | +$1.03K | ﹤0.01% | 2695 |
|
|
2023
Q3 | $68 | Hold |
20
| – | – | ﹤0.01% | 2559 |
|
|
2023
Q2 | $147 | Hold |
20
| – | – | ﹤0.01% | 2399 |
|
|
2023
Q1 | $207 | Sell |
20
-24
| -55% | -$248 | ﹤0.01% | 2193 |
|
|
2022
Q4 | $520 | Buy |
+44
| New | +$520 | ﹤0.01% | 1824 |
|